type

3D printing breakthrough: Scientists create functional human islets for type 1 diabetes treatment - EurekAlert!

Receipt of buprenorphine and naltrexone for opioid use disorder by race and ethnicity and insurance type - EurekAlert!

C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes - EurekAlert!

Clinical trial for teens shows improved health outcomes for type 1 diabetes - EurekAlert!

Language disparities in continuous glucose monitoring for type 2 diabetes - EurekAlert!

Fatty liver – but not liver damage – common in type 2 diabetes - EurekAlert!

New genetic clues explain speed of insulin depletion in Japanese patients with type 1 diabetes - EurekAlert!

Early and midterm outcomes of concomitant coronary artery bypass grafting for coronary artery disease in surgical repair of type A aortic dissection - EurekAlert!

Rising T1DE alliance adds Lurie Children’s to further disseminate new data-driven care model for type 1 diabetes - EurekAlert!

Intensive weight loss programme improves eating disorder symptoms in people with Type 2 Diabetes at risk of eating disorders, Oxford study finds - EurekAlert!

First clinical practice guideline on lifestyle interventions for treatment and remission of type 2 diabetes and prediabetes in adults is published - EurekAlert!

This Type of Fiber Could Have Weight Loss Benefits Similar to Ozempic

Genetics and therapy type determine second cancer risk after childhood treatment

Why Women With Type 2 Diabetes Are Diagnosed Later Than Men

One Type of Mammogram Proves Better for Women With Dense Breasts

Can the brain be targeted to treat type 2 diabetes?

Can the brain be targeted to treat type 2 diabetes? - EurekAlert!

Science sleuths flag hundreds of papers that use AI without disclosing it. They have identified hundreds of cases in which AI tools seem to have been used without disclosure. According to some, this type of quiet change is a potential threat to scientific integrity.

Dual-action approach targeting inflammation shows potential as Type 1 diabetes treatment

Risk groups for type 2 diabetes can also be identified at an older age